Illumina’s NGS sequencers are used to sequence DNA or RNA samples and use a technology known as sequencing by synthesis (SBS) to enhance DNA short-read sequence generation. According to a ...

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...

Roche, Illumina and Life Technologies ... can be added to the fragmented DNA by appending to the transposon end sequence an engineered adaptor sequence. After extension, the sequencing adaptors ...

Illumina Inc's NovaSeq X Plus gene sequencing system is shown in this undated handout photo obtained by Reuters ...

Illumina Inc. added activist investor Keith Meister to its board and elevated director Scott Gottlieb, a former head of the ...

empowering customers to sequence more sustainably. Additionally, for the third consecutive year, Illumina procured 100% renewable energy for its operations through on-site generation, purchased ...

Identification of pathogenic DNA sequence alterations in patients with ... can process data from all major platforms (Roche 454, Illumina Genome Analyzer and ABI SOLiD). MutationTaster hence ...

March 10 (Reuters) - Illumina (ILMN.O), opens new tab on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue from China, after the country banned the importation of its DNA ...

(Reuters) -Illumina on Monday lowered its annual forecast ... Gene sequencers help determine the sequence of DNA or RNA, allowing scientists to study genetic variations associated with diseases ...

Illumina faces significant challenges from China's "unreliable entity list" and competition from Roche's new SBX technology, impacting its growth prospects. Despite a 37% stock decline since ...